US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomarin Pharmaceutical

61.53

-1.1800-1.88%

Volume:687.58K

Turnover:42.89M

Market Cap:11.80B

PE:27.88

High:65.40

Open:64.26

Low:60.92

Close:62.71

Loading ...

Overview Company News Filings

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock

2 Reasons to Like BMRN (and 1 Not So Much)

Is BioMarin Pharmaceutical Inc. (BMRN) a Promising Biotech Stock According to Wall Street Analysts

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?

BioMarin Pharmaceutical (BMRN): Among Paul Singer’s Latest Portfolio’s Top Stock Picks

BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

INCY Stock Down on Disappointing Skin Disease Study Data

BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?

Is BioMarin Pharmaceutical (BMRN) the Best Biotech Stock According to Billionaires?

AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies

NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study

PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study

BEAM Down Despite Positive Initial Data From Genetic Disorder Study

KOD Completes Enrollment in Phase III Study for Eye Disease Candidate

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BMRN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","market":"US","secType":"STK","nameCN":"Biomarin Pharmaceutical","latestPrice":61.53,"timestamp":1746201538095,"preClose":62.71,"halted":0,"volume":687578,"delay":0,"floatShares":179589016,"shares":191754170,"eps":2.207261,"marketStatus":"Trading","change":-1.18,"latestTime":"05-02 11:58:59 EDT","open":64.255,"high":65.4,"low":60.92,"amount":42889209.673784,"amplitude":0.07144,"askPrice":61.6,"askSize":8,"bidPrice":61.51,"bidSize":4,"shortable":3,"etf":0,"ttmEps":2.207261,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746216000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":932702400000,"exchange":"NASDAQ","adjPreClose":62.71,"preHourTrading":{"tag":"盘前","latestPrice":64.59,"preClose":62.71,"latestTime":"09:28 EDT","volume":193,"amount":12463.418899999999,"timestamp":1746192480011},"postHourTrading":{"tag":"盘后","latestPrice":63.95,"preClose":62.71,"latestTime":"19:55 EDT","volume":172845,"amount":10856603.943,"timestamp":1746143756805},"volumeRatio":1.400787,"impliedVol":0.3213,"impliedVolPercentile":0.38},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","floatShares":179589016,"roa":"5.15%","roe":"8.05%","lyrEps":2.246307,"volumeRatio":1.400787,"shares":191754170,"dividePrice":0,"high":65.4,"amplitude":0.07144,"preClose":62.71,"low":60.92,"week52Low":52.93,"pbRate":"2.09","psRate":"4.13","week52High":94.85,"institutionHeld":0.9275,"latestPrice":61.53,"committee":-0.333333,"eps":2.207261,"divideRate":0,"volume":687578,"delay":0,"ttmEps":2.207261,"open":64.255,"prevYearClose":65.73,"prevWeekClose":63.3,"prevMonthClose":63.69,"prevQuarterClose":70.69,"fiveDayClose":63.3,"twentyDayClose":67.48,"sixtyDayClose":64.185},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMRN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522822504","title":"Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2522822504","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522822504?lang=en_us&edition=fundamental","pubTime":"2025-03-28 21:50","pubTimestamp":1743169805,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.Is This 1 Momentum Stock a Screaming Buy Right Now?For momentum investors, upward or downward trends in a stock's price or earnings outlook take precedent, so they'll want to zero in on the Momentum Style Score. This Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.San Rafael, CA-based BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for life-threatening severe medical conditions, mainly for chi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-biomarin-pharmaceutical-bmrn-135005268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4139","BK4566","BMRN"],"gpt_icon":0},{"id":"2522807335","title":"2 Reasons to Like BMRN (and 1 Not So Much)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522807335","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522807335?lang=en_us&edition=fundamental","pubTime":"2025-03-26 17:11","pubTimestamp":1742980303,"startTime":"0","endTime":"0","summary":"Since September 2024, BioMarin Pharmaceutical has been in a holding pattern, floating around $70.24.Or does the price properly account for its business quality and fundamentals?Find out in our full research report, it’s free.Pioneering treatments for conditions that often had no previous therapeutic options, BioMarin Pharmaceutical  develops and commercializes therapies that address the root causes of rare genetic disorders, particularly those affecting children.A company’s long-term sales performance can indicate its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Over the last five years, BioMarin Pharmaceutical grew its sales at a decent 10.9% compounded annual growth rate. Its growth was slightly above the average healthcare company and shows its offerings resonate with customers.Get started by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have ge","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/2-reasons-bmrn-1-not-091143795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4566","IE0002270589.USD","BMRN","BK4139"],"gpt_icon":0},{"id":"2522625851","title":"Is BioMarin Pharmaceutical Inc. (BMRN) a Promising Biotech Stock According to Wall Street Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2522625851","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522625851?lang=en_us&edition=fundamental","pubTime":"2025-03-26 09:18","pubTimestamp":1742951911,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we are going to look at where BioMarin Pharmaceutical Inc.  stands against other biotech stocks.Biotech Sector Set for Growth Amid Innovation and Investor Interest. The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention. The industry has recovered from a challenging 2024 and is poised for significant expansion led by advances in personalized medicine, AI-driven drug discovery, and growing demand for biologics. MarketsandMarkets predicted that the global biotech market would expand by a strong 13%, from $483.0 billion in 2024 to $546.0 billion in 2025. This expansion demonstrates the sector’s tenacity and promise for growth.For this article, we shortlisted stocks that met the following criteria: a market capitalization of over $2 billion","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biomarin-pharmaceutical-inc-bmrn-promising-011831244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4566","IE00B19Z3581.USD","USAW.SI","IE0002270589.USD","IE00B19Z3B42.SGD","QLD","SQQQ","NVIW.SI",".IXIC","BK4139","IE00B7SZLL34.SGD","MNQmain","TQQQ","USJW.SI","TSYW.SI","QID","BMRN","PSQ","NQmain"],"gpt_icon":1},{"id":"2521717287","title":"Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2521717287","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521717287?lang=en_us&edition=fundamental","pubTime":"2025-03-24 17:01","pubTimestamp":1742806869,"startTime":"0","endTime":"0","summary":"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna  and the best and worst performers in the therapeutics industry.Over the next few years, therapeutic companies, which develop a wide variety of treatments for diseases and disorders, face strong tailwinds from advancements in precision medicine  and growing demand for treatments targeting rare diseases. However, headwinds such as rising scrutiny over drug pricing, regulatory unknowns, and competition from larger, more resourced pharmaceutical companies could weigh on growth.The 10 therapeutics stocks we track reported a satisfactory Q4. As a group, revenues beat analysts’ consensus estimates by 2.6%.In light of this news, share prices of the companies have held steady. On average, they are relatively unchanged since the latest earnings results.Rising to global prominence during the COVID-19 pandemic with one of the first ef","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-rundown-moderna-nasdaq-mrna-090109783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1267930490.SGD","LU0965509010.AUD","IE00B19Z3B42.SGD","LU0965508806.USD","IE0002141913.USD","NDAQ","LU1934455194.USD","USJW.SI","QID","BMRN","USAW.SI","SQQQ","LU2129689514.USD","LU0203347892.USD","MRNA","IE00BDGV0183.EUR","LU0985320562.USD","LU1585245621.USD","LU0234572021.USD","LU1244550494.USD","IE0009355771.USD","QLD","IE00B64PRP62.GBP","BK4534","NVIW.SI","LU0234570918.USD","BK4533","LU0456855351.SGD","SG9999015986.USD","LU0158827948.USD","IE00B3QW5Z07.USD","IE00BFTCPJ56.SGD","SRPT","LU2237443622.USD","SG9999003800.SGD","PSQ","LU0417517546.SGD","LU2089283258.USD","BK4550","TQQQ","NQmain","TSYW.SI","BK4551","MNQmain","BIIB","LENZ","ABBV",".IXIC","LU1244550577.SGD"],"gpt_icon":1},{"id":"2521230768","title":"BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521230768","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521230768?lang=en_us&edition=fundamental","pubTime":"2025-03-21 23:30","pubTimestamp":1742571028,"startTime":"0","endTime":"0","summary":"A month has gone by since the last earnings report for BioMarin Pharmaceutical . Shares have added about 4.2% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is BioMarin due for a pullback?Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.It turns out, estimates review have trended upward during the past month.The consensus estimate has shifted 14.31% due to these changes.BioMarin is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Alnylam Pharmaceuticals , a stock from the same industry, has gained 1%. The company reported its results for the quarter ended December 2024 more than a month ago.Alnylam Pharmaceuticals, Inc.  : Free Stock Analysis Report. This article originally published on Zacks Investment Research .","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biomarin-bmrn-4-2-since-153028778.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALNY","BMRN"],"gpt_icon":0},{"id":"2521495660","title":"BioMarin Pharmaceutical (BMRN): Among Paul Singer’s Latest Portfolio’s Top Stock Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2521495660","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521495660?lang=en_us&edition=fundamental","pubTime":"2025-03-21 03:25","pubTimestamp":1742498722,"startTime":"0","endTime":"0","summary":"We recently published a list of Paul Singer’s Latest Portfolio: Top 10 Stock Picks. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc.  stands against other top stock picks from Paul Singer’s latest portfolio.Stock markets are as risky as they have ever been. That’s the sentiment echoed by billionaire investor Paul Singer. The sentiment comes as the overall equity market has turned bearish, with major indices pulling back from record highs. The S&P 500 is already down by 10% and is officially in the correction phase, a development triggered by a string of developments.A ferocious trade tariffs spat triggered by US President Donald Trump has sent shockwaves in the market, fueling a string of sell-offs. Similarly, growing concerns about the global economy plunging into recession amid a trade spat between the US and its allies have also unsettled the markets.Amid the growth, the fund suffered a major setback when its second most senior staffer jumped ship f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biomarin-pharmaceutical-bmrn-among-paul-192522840.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MNQmain","SQQQ","QLD","USAW.SI","USJW.SI","TSYW.SI","NQmain","IE0002270589.USD","IE00B19Z3B42.SGD","TQQQ","BMRN","BK4566","QID","NVIW.SI","IE00B19Z3581.USD",".IXIC","IE00B7SZLL34.SGD","BK4139","PSQ"],"gpt_icon":1},{"id":"2520956457","title":"BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2520956457","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520956457?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:00","pubTimestamp":1742475600,"startTime":"0","endTime":"0","summary":"New data also to be presented for PALYNZIQ , reinforcing its value in sustaining blood Phe level reduction and improving health-related quality of life for adults with phenylketonuria. SAN RAFAEL, Calif., March 20, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc.  today announced positive new data from studies of VOXZOGO in children with achondroplasia and in ongoing clinical trials investigating other skeletal conditions, as well as PALYNZIQ in adults with phenylketonuria . The latest findings further validate the long-term benefit and established safety profiles of both medicines, which continue to play a pivotal role for people living with these genetically defined conditions.PALYNZIQ Data Show Importance of Sustained Blood Phe Level Reduction and Improvement in Quality of Life in Adults with PKU","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biomarin-presents-data-demonstrating-favorable-130000558.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biomarin-presents-data-demonstrating-favorable-130000558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BMRN","AFG"],"gpt_icon":0},{"id":"2520089932","title":"INCY Stock Down on Disappointing Skin Disease Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2520089932","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520089932?lang=en_us&edition=fundamental","pubTime":"2025-03-19 03:00","pubTimestamp":1742324400,"startTime":"0","endTime":"0","summary":"Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis suppurativa .HS, a chronic inflammatory skin condition, is characterized by painful nodules and abscesses.While both the late studies STOP-HS1 and STOP-HS2 studies met their primary endpoint, the results lagged investor expectations, and consequently, shares declined.Povorcitinib is an oral small-molecule JAK1 selective inhibitor currently in phase III studies for HS, vitiligo and prurigo nodularis , as well as phase II trials for asthma and chronic spontaneous urticaria .The phase III studies STOP-HS1  and STOP-HS2  are evaluating the efficacy and safety of povorcitinib in adult patients with moderate to severe HS. Both studies include a 12-week double-blind, placebo-controlled treatment period, followed by a 42-week extension period and 30-day safety follow-up.Data from the STOP-HS2 study s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incy-stock-down-disappointing-skin-190000520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234570918.USD","LU1066051498.USD","GSK","QD","BK4583","BK4503","LU0320765992.SGD","LU0058720904.USD","GILD","IE00B3T34201.USD","INCY","LU0889565916.HKD","IE00BKVL7J92.USD","PN","LU1585245621.USD","LU2087621335.USD","BK4214","LU1169589451.USD","BK4566","LU1169590202.USD","BK4568","BK4578","BK4588","IE0002270589.USD","IE00BZ1G4Q59.USD","BK4007","BK4532","IE00B19Z3581.USD","LU1430594728.SGD","LU2089984988.USD","LU0289739699.SGD","LU1571399168.USD","IE00BSNM7G36.USD","LU1839511570.USD","LU1066053197.SGD","LU1829250122.USD","BK4585","IE00B19Z3B42.SGD","BK4139","BK4166","IE00B7SZLL34.SGD","BMRN","GSK.UK","BK4550","LU0109394709.USD","LU2468319806.SGD","AN","BK4563"],"gpt_icon":0},{"id":"2520202989","title":"BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520202989","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520202989?lang=en_us&edition=fundamental","pubTime":"2025-03-18 23:40","pubTimestamp":1742312407,"startTime":"0","endTime":"0","summary":"Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical  or CSL Limited Sponsored ADR . But which of these two stocks is more attractive to value investors?We'll need to take a closer look to find out.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.BioMarin Pharmaceutical and CSL Limited Sponsored ADR are sporting Zacks Ranks of #2  and #3 , respectively, right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that BMRN has an improving earnings outlook. But this is just one factor that value investors ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bmrn-vs-cslly-stock-value-154007253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IE0002270589.USD","IE00B7SZLL34.SGD","BK7501","BK4139","CSL.AU","CSLLY","ISBC","IE00B19Z3B42.SGD","BMRN","BK7067","BK7508","BK4566","IE00B19Z3581.USD","BK4211","BK7511"],"gpt_icon":1},{"id":"2520649582","title":"Is BioMarin Pharmaceutical (BMRN) the Best Biotech Stock According to Billionaires?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520649582","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520649582?lang=en_us&edition=fundamental","pubTime":"2025-03-18 17:55","pubTimestamp":1742291720,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc.  stands against other best biotech stocks.Although biotech stocks had a “challenging” year in 2024, JPMorgan believes that some of the industry’s companies could see significant growth in the months to come. Senior partner and principal of investments at Novo Holdings, Johan Hueffer, spoke on CNBC on November 28 about his macro outlook for life sciences investments. He claimed that in the past few years, biotechs have had trouble raising funding. Over the past quarter or two, though, that tendency has begun to improve.Flood’s report also emphasized how the biotech sector has recently demonstrated better fundamentals, which have been ascribed to superior clinical outcomes and a more favorable regulatory environment. Goldman’s data shows that hedge funds continue to underinvest in biotechnology despite these tailwin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biomarin-pharmaceutical-bmrn-best-biotech-095520892.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","BK4504","LU2750360997.AUD","US5Y.BOND","IE00BFXG1179.USD","USJW.SI","IE00BSNM7G36.USD","LU0096364046.USD",".IXIC","LU2750360641.GBP","LU2237443978.SGD","LU0106831901.USD","BMRN","BK4550","BK4552","MNQmain","LU1868836591.USD","QID","US10Y.BOND","IE00B19Z3B42.SGD","US12M.BOND","QLD","US30Y.BOND","US2Y.BOND","TQQQ","US7Y.BOND","LU1868836914.USD","LU2237443382.USD","FOMC","BK4533","TSYW.SI","BK4516","USAW.SI","SQQQ","PSQ","NQmain","IE0004086264.USD","US3Y.BOND","LU2471134796.USD","LU1668664300.SGD","LU1791807156.HKD","US6M.BOND","LU2471134952.CNY","LU2471134879.HKD","IE00B19Z3581.USD","LU2237443895.HKD","NVIW.SI","BK4588"],"gpt_icon":1},{"id":"2520570285","title":"AZN's Imfinzi Gets EU Nod for Limited-Stage Small-Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2520570285","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520570285?lang=en_us&edition=fundamental","pubTime":"2025-03-17 23:10","pubTimestamp":1742224200,"startTime":"0","endTime":"0","summary":"AstraZeneca AZN recently announced that the European Commission has approved its blockbuster cancer drug Imfinzi  as monotherapy for treating limited-stage small cell lung cancer  in adult patients whose disease has not progressed following platinum-based chemoradiation therapy .The latest approval for Imfinzi in the European Union  was based on data from the phase III ADRIATIC study.Data from the phase III ADRIATIC study showed that treatment with Imfinzi reduced the risk of death by 27% as compared to placebo. Additionally, treatment with Imfinzi reduced the risk of disease progression or death by 24% versus placebo.The approval in the EU was expected as the Committee for Medicinal Products for Human Use recommended approval of Imfinzi as monotherapy for treating LS-SCLC in adult patients whose disease has not progressed following platinum-based CRT in February 2025.The FDA approved Imfinzi for a similar indication in December 2024.Hypoparathyroidism patients suffer from a deficiency","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azns-imfinzi-gets-eu-nod-151000804.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z3B42.SGD","LU0889565916.HKD","BMRN","IE00B7SZLL34.SGD","BK4007","ARVN","BK4585","LU0320765992.SGD","BK4588","BK4566","AZN","BK4139","IE0002270589.USD","BK4156","SSI","BK4568","LU2236285917.USD","IE00B19Z3581.USD","LU0109394709.USD","BK4213","LU2462157665.USD","LU2417539215.USD","CRT","DVAX","LU1829250122.USD","LU2456880835.USD"],"gpt_icon":0},{"id":"2520157674","title":"Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2520157674","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520157674?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:45","pubTimestamp":1742219110,"startTime":"0","endTime":"0","summary":"Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike.Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum.Why This 1 Growth Stock Should Be On Your Watchlist. Different than value or momentum investors, growth-oriented investors are concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, they'll want to focus on the Growth Style Score, which analyzes characteristics like projected and historical earnings, sales, and cash flow to find stocks that will see sustainable growth over time.Nine analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.30 to $","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/heres-why-biomarin-pharmaceutical-bmrn-134510442.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","BMRN","IE00B19Z3581.USD","BK4139","BK4566","IE0002270589.USD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2520576748","title":"AZN to Acquire EsoBiotec for $1B to Develop In Vivo Cell Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2520576748","media":"Zacks","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520576748?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:38","pubTimestamp":1742218680,"startTime":"0","endTime":"0","summary":"AstraZenecaAZN announced that it has entered into a definitive agreement to acquire EsoBiotec for developing in vivo cell therapies for multiple cancer indications or immune-mediated diseases. EsoBiotec is a biotechnology company specializing in “in vivo” cell therapies with promising early clinical results.The acquisition will integrate EsoBiotec’s proprietary ENaBL platform, which empowers the immune system’s ability to target cancers, into AstraZeneca’s portfolio. This technology has the potential to expand patient access to transformative cell therapy treatments, delivering results in minutes instead of the current weeks-long process. The deal will allow EsoBiotec to leverage AZN’s vast resources and expertise in cell therapies to accelerate the development of their in vivo platform which has a novel delivery technology that is expected to have broad therapeutic applicability.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azn-acquire-esobiotec-1b-develop-133800753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234570918.USD","LU1066051498.USD","AZN","BK4583","LU0320765992.SGD","LU2456880835.USD","LU0058720904.USD","GILD","IE00B3T34201.USD","LU2462157665.USD","LU0889565916.HKD","LU1585245621.USD","LU2087621335.USD","CORT","BK4566","BK4568","BK4578","BK4588","IE0002270589.USD","IE00BZ1G4Q59.USD","LU2236285917.USD","BK4007","IE00B19Z3581.USD","BK4532","LU1430594728.SGD","LU2089984988.USD","LU0289739699.SGD","LU1571399168.USD","IE00BSNM7G36.USD","LU1839511570.USD","LU1066053197.SGD","LU1829250122.USD","LU2417539215.USD","BK4585","IE00B19Z3B42.SGD","BK4139","IE00B7SZLL34.SGD","LU1559883803.SGD","BMRN","BK4550","LU0109394709.USD","LU2468319806.SGD","LU0566484027.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2518477984","title":"NVO Stock Down 9% as CagriSema Misses Target in Second Obesity Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518477984","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518477984?lang=en_us&edition=fundamental","pubTime":"2025-03-12 01:51","pubTimestamp":1741715460,"startTime":"0","endTime":"0","summary":"Novo Nordisk NVO has achieved the primary endpoint in the second late-stage study evaluating its next-gen subcutaneous obesity treatment candidate, CagriSema, in patients with obesity and type 2 diabetes  and a mean baseline body weight of 102 kg. The results showed that treatment with the candidate led to a statistically significant and superior weight loss at week 68compared with placebo.NVO’s CagriSema is a fixed-dose combination of a long-acting amylin analogue, cagrilintide 2.4 mg and Wegovy. The two molecules promote weight loss by suppressing hunger, enhancing feelings of fullness and helping individuals consume fewer calories.The phase III REDEFINE 2 study followed a flexible protocol, enabling patients to adjust their dosing throughout the study. After 68 weeks, 61.9% of those treated with CagriSema reached the highest dose.Novo Nordisk plans to submit a regulatory application seeking the first approval for CagriSema for the obesity indication in the first quarter of 2026. Det","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvo-stock-down-9-cagrisema-175100065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002270589.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4583","IE00B7SZLL34.SGD","LU2468319806.SGD","BK4585","BK4139","BK4550","NVO","CORT","IE00BSNM7G36.USD","LU0058720904.USD","BK4588","LU0289739699.SGD","LU1571399168.USD","LU1093756168.USD","LU2087621335.USD","BK4568","BK4566","LU1430594728.SGD","LU1585245621.USD","LU2089984988.USD","IE00BKVL7J92.USD","LU0320765992.SGD","BK4578","IE00B19Z3581.USD","LU1093756325.SGD","BMRN","GILD","BK4599","BK4007","LU0234570918.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","LU0566484027.USD","BK4532","LU0889565916.HKD","LU1839511570.USD","IE00B3T34201.USD","LU0154236417.USD","LU1559883803.SGD"],"gpt_icon":1},{"id":"2518727781","title":"PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518727781","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518727781?lang=en_us&edition=fundamental","pubTime":"2025-03-12 00:15","pubTimestamp":1741709700,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics, Inc. PTGX announced positive top-line data from the phase IIb ANTHEM-UC study, which evaluated icotrokinra , an investigational targeted oral peptide that selectively blocks the IL-23 receptor, for treating adults with moderately to severely active ulcerative colitis , a chronic disease of the large intestine.The ANTHEM-UC study, conducted by Protagonist's partner, Johnson & Johnson JNJ, met its primary endpoint of clinical response in all icotrokinra dose groups.Treatment with icotrokinra also demonstrated clinically meaningful differences in key secondary endpoints of clinical remission, symptomatic remission and endoscopic improvement at week 12 versus placebo in the ANTHEM-UC study.Shares of PTGX were up 45.9% on March 10 following the announcement of the news.In the past year, shares of Protagonist have rallied 87.4% against the industry’s decline of 8.5%.The randomized, placebo-controlled phase IIb ANTHEM-UC study evaluated the safety and efficacy of thr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ptgx-j-j-partnered-drug-161500020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFXG1179.USD","SG9999002232.USD","IE00BGHQF631.EUR","LU1291159041.SGD","LU1323610961.USD","BMRN","LU2360032135.SGD","LU1914381329.SGD","LU1023059063.AUD","LU1868836591.USD","LU2602419157.SGD","BK4585","BK4534","LU2347655156.SGD","BK4007","LU1585245621.USD","LU1989771016.USD","LU2430703178.SGD","BK4581","BMY","LU0795875086.SGD","LU1061106388.HKD","LU0345770993.USD","LU1732800096.USD","LU1066051498.USD","LU2468319806.SGD","IE00BVYPNV92.GBP","LU2125154778.USD","LU1674673428.USD","BK4532","LU0640476718.USD","BK4592","JNJ","LU1929549753.HKD","IE00B2B36J28.USD","PTGX","LU2133065610.SGD","LU0098860793.USD","IE00B42XCP33.USD","IE00B4R5TH58.HKD","LU1244550577.SGD","LU2129689431.USD","LU1244550221.USD","IE0034235303.USD","LU0203347892.USD","LU2125154935.USD","LU0792757196.USD","IE000M9KFDE8.USD","BK4588","LU1221951046.USD"],"gpt_icon":0},{"id":"2518272677","title":"BEAM Down Despite Positive Initial Data From Genetic Disorder Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272677","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518272677?lang=en_us&edition=fundamental","pubTime":"2025-03-12 00:07","pubTimestamp":1741709220,"startTime":"0","endTime":"0","summary":"Beam Therapeutics Inc. BEAM announced positive initial safety and efficacy data from a phase I/II study, which is evaluating its pipeline candidate, BEAM-302, for treating patients with alpha-1 antitrypsin deficiency .Currently, there are no approved curative treatments for the given indication.Data from the study showed that treatment with a single dose of BEAM-302 demonstrated durable, dose-dependent increases in total and functional alpha-1 antitrypsin . Also, new production of corrected protein  and decreases in toxic mutant Z-AAT were observed in circulation across the initial three doses.All three patients treated with BEAM-302  achieved a mean total AAT of 12.4M at day 28, exceeding the 11M protective therapeutic threshold. Also, treatment with BEAM-302  reduced mutant Z-AAT up to 78%.The initial safety finding suggests that treatment with BEAM-302 was well tolerated across all dose levels, leading to durable dose-dependent correction of the disease-causing mutation.Despite the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beam-down-despite-positive-initial-160700470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BEAM","BK4588","ANIX","AAT","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","BK4611","BK4556","BMRN","BK4585","BK4566","XNCR","BK4160","BK4535","BK4139","IE0002270589.USD","IE00B19Z3581.USD","BK4505"],"gpt_icon":0},{"id":"2518072238","title":"KOD Completes Enrollment in Phase III Study for Eye Disease Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518072238","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518072238?lang=en_us&edition=fundamental","pubTime":"2025-03-11 22:39","pubTimestamp":1741703940,"startTime":"0","endTime":"0","summary":"Kodiak SciencesKOD announced that it has completed enrollment in a late-stage study of tarcocimab tedromer in patients with diabetic retinopathy . Per KOD, more than 250 patients have been enrolled in the phase III GLOW2 study, surpassing the initial enrollment target. With a 48-week treatment duration, all patients are expected to complete their primary endpoint visits by the end of January 2026. The top-line clinical data is anticipated to be announced in the first quarter of 2026.In late 2023, Kodiak rebooted the development program of tarcocimab following positive phase III results from the GLOW1 study, which evaluated the treatment in patients with moderately severe to severe non-proliferative diabetic retinopathy. Leveraging the GLOW1 study's success, Kodiak initiated the GLOW2 study to further investigate tarcocimab for DR and began dosing patients in May 2024. Enrolled DR patients will receive tarcocimab on extended dosing intervals, including six-month dosing for all patients.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kod-completes-enrollment-phase-iii-143900570.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","LU0320765992.SGD","LU1559883803.SGD","IE0009356076.USD","IE00B19Z3581.USD","LU1803068979.SGD","KOD","LU0056508442.USD","LU2250418816.HKD","LU0109394709.USD","BK4573","BK4578","LU1880398554.USD","IE00B19Z3B42.SGD","BK4550","LU0823434583.USD","LU1988902786.USD","LU2098885051.SGD","LU2054465674.USD","LU1066051498.USD","LU2458330169.SGD","LU1951198990.SGD","LU0889565833.HKD","IE00BSNM7G36.USD","LU0642271901.SGD","BK4585","LU1839511570.USD","BMRN","CORT","LU1951200564.SGD","LU0390134368.USD","LU2360106780.USD","LU0889565916.HKD","BK4612","GILD","BK4554","IE00B3T34201.USD","III","LU0719512351.SGD","BK4575","LU2089984988.USD","LU2468319806.SGD","LU0082616367.USD","LU2458330243.SGD","BK4614","LU0127658192.USD","LU1923623000.USD","BK4141","LU1316542783.SGD"],"gpt_icon":1},{"id":"2518745099","title":"PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2518745099","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518745099?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:05","pubTimestamp":1741691100,"startTime":"0","endTime":"0","summary":"BOSTON, March 11, 2025----PureTech Health plc  , a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics,  a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Robert \"Bob\" J. Hombach has been appointed to its Board of Directors and will serve as the Chair of the Audit Committee. Mr. Hombach is a seasoned financial and operational executive with three decades of high-level leadership in the healthcare sector. His experience includes serving on the Audit, Finance and Compensation Committees for several public and private Boards of Directors, such as FORTUNE 500 companies like BioMarin , where he also chairs the Audit Committee, and Henry Schein , a member of the S&P 500 index.The full text of the announcement from Seaport is as follows:. Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/puretech-founded-entity-seaport-therapeutics-110500549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4504","SQQQ","LU0211327993.USD",".IXIC","MNQmain","EMBC","BK4139","USAW.SI","LU0162691827.USD","BK4585","QLD","LU0006061336.USD","PRTC","BK4588","IE00B7SZLL34.SGD","NVIW.SI","LU0310799852.SGD","TSYW.SI","LU0211328371.USD","QID","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BK4198","BK4082","NQmain","LU2098885051.SGD","TQQQ","LU1267930490.SGD","HSIC","USJW.SI","IE0002270589.USD","PSQ","BK4566","BK4175","BAX","LU0072461881.USD","LU1303367103.USD","LENZ","BMRN"],"gpt_icon":1},{"id":"2518719948","title":"Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2518719948","media":"StockStory","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518719948?lang=en_us&edition=fundamental","pubTime":"2025-03-11 17:03","pubTimestamp":1741683790,"startTime":"0","endTime":"0","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting  results from Q4. Today, we are looking at therapeutics stocks, starting with Myriad Genetics .Over the next few years, therapeutic companies, which develop a wide variety of treatments for diseases and disorders, face strong tailwinds from advancements in precision medicine  and growing demand for treatments targeting rare diseases. However, headwinds such as rising scrutiny over drug pricing, regulatory unknowns, and competition from larger, more resourced pharmaceutical companies could weigh on growth.The 10 therapeutics stocks we track reported a satisfactory Q4. As a group, revenues beat analysts’ consensus estimates by 2.6%.Thankfully, share prices of the companies have been resilient as they are up 5.2% on average since the latest earnings results.Founded in 1991, Myriad Genetics  provides genetic testing and precision medicine solutions, with a focus on identifying hereditary risks","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/winners-losers-q4-myriad-genetics-090310721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ","LU1066051498.USD","IE00B2B36J28.USD","QLD","LU0320765992.SGD","LU1732800096.USD","LU0198837287.USD","ABBV","LU0738911758.USD","GILD","MYGN","LU1989771016.USD","NVIW.SI","USJW.SI","LU1989763690.USD","MNQmain","IE00BGHQF631.EUR","IE0002141913.USD","LU0965508806.USD","LU1496350171.SGD","LU1037948897.HKD","BK4568","NQmain","IE00BZ1G4Q59.USD","LU0689472784.USD","LU1934455194.USD","LU0820561818.USD","LU1093756325.SGD","LENZ","TQQQ","LU0882574055.USD","BK4112","LU0170899867.USD","LU1267930490.SGD","LU1291159041.SGD","LU0661504455.SGD","ABT","LU2210150020.SGD","TSYW.SI","NDAQ","BK4139","QID","SG9999001440.SGD","USAW.SI","BMRN","LU0456855351.SGD","PSQ",".IXIC"],"gpt_icon":1},{"id":"2518042952","title":"Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2518042952","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518042952?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:11","pubTimestamp":1741630260,"startTime":"0","endTime":"0","summary":"Teladoc Health, Inc. TDOC recently announced that it is expanding access to clinically responsible weight management treatments by integrating with Eli Lilly’s LillyDirect pharmacy partner, Gifthealth. This strategic move is set to benefit Teladoc’s Comprehensive Weight Care, as it enhances accessibility to FDA-approved Zepbound for eligible members seeking effective weight management solutions.The integration will streamline the prescription, fulfillment, and delivery process for Teladoc’s members who are prescribed Zepbound for obesity. With direct access to LillyDirect, members without insurance coverage for GLP-1 medications can now receive affordable and reliable weight management treatments at home. This offering is expected to drive higher patient engagement and sustained outcomes, supporting Teladoc’s mission to deliver evidence-based and affordable care.By capitalizing on the growing demand for GLP-1 medications and offering end-to-end support for weight management, Teladoc is","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teladoc-boosts-weight-care-access-181100483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","BK4585","TDOC","BK4185","BK4548","BK4139","LU1861558580.USD","LU1861559042.SGD","BMRN","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BK4504","LU2065731478.USD","OPCH","IE00B19Z3B42.SGD","BK4167","BK4566","BK4196","BK4567","ENSG","IE0002270589.USD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMRN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-01","symbol":"BMRN","fiscalQuarterEnding":"2025/03","expectedEps":0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"post","actualEps":0.49},{"market":"US","date":"2025-02-19","symbol":"BMRN","fiscalQuarterEnding":"2024/12","expectedEps":0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"post","actualEps":0.72},{"market":"US","date":"2024-10-29","symbol":"BMRN","fiscalQuarterEnding":"2024/09","expectedEps":0.57,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730174400000,"reportTimeType":"post","actualEps":0.74},{"market":"US","date":"2024-08-05","symbol":"BMRN","fiscalQuarterEnding":"2024/06","expectedEps":0.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722830400000,"reportTimeType":"post","actualEps":0.77},{"market":"US","date":"2024-04-24","symbol":"BMRN","fiscalQuarterEnding":"2024/03","expectedEps":0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMRN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3448,"buy":0.4483,"hold":0.2069,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4483,"analysts":29,"updateTime":1740456000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMRN","date":"2025-05-01","current":28.610907,"percent":0.249796,"low":-246.955768,"twenty":18.510369,"median":112.838199,"eighty":244.603325,"high":1069.125802,"avg":172.218239,"sd":250.33871,"marketCap":12212823087},"quantilePoints":[{"date":"2020-05-08","current":151.00669,"twenty":-146.720429,"median":-112.32011,"eighty":-70.459717,"marketCap":17215668691},{"date":"2020-05-15","current":148.690831,"twenty":-146.720429,"median":-112.264026,"eighty":-67.95747,"marketCap":16951646881},{"date":"2020-05-22","current":154.670823,"twenty":-146.720429,"median":-112.009509,"eighty":-65.875106,"marketCap":17633401828},{"date":"2020-05-29","current":169.010114,"twenty":-146.720429,"median":-111.583861,"eighty":-65.266721,"marketCap":19268167006},{"date":"2020-06-05","current":167.82046,"twenty":-146.720429,"median":-111.430067,"eighty":-53.616205,"marketCap":19132539364},{"date":"2020-06-12","current":167.693564,"twenty":-146.720429,"median":-111.166002,"eighty":-52.32921,"marketCap":19118072416},{"date":"2020-06-19","current":196.879731,"twenty":-146.720429,"median":-110.643992,"eighty":-51.800638,"marketCap":22445470566},{"date":"2020-06-26","current":196.72111,"twenty":-146.720429,"median":-110.454206,"eighty":-51.112661,"marketCap":22427386881},{"date":"2020-07-02","current":201.099035,"twenty":-146.720429,"median":-110.047751,"eighty":-50.787838,"marketCap":22926496603},{"date":"2020-07-10","current":199.956968,"twenty":-146.720429,"median":-109.640088,"eighty":-50.663322,"marketCap":22796294067},{"date":"2020-07-17","current":203.367308,"twenty":-146.720429,"median":-109.199968,"eighty":-50.401769,"marketCap":23185093307},{"date":"2020-07-24","current":195.023871,"twenty":-146.720429,"median":-109.08296,"eighty":-50.291122,"marketCap":22233891445},{"date":"2020-07-31","current":190.043188,"twenty":-146.720429,"median":-108.761911,"eighty":-50.018415,"marketCap":21666063717},{"date":"2020-08-07","current":176.02739,"twenty":-146.720429,"median":-108.266562,"eighty":-49.711244,"marketCap":21520756675},{"date":"2020-08-14","current":175.270889,"twenty":-146.720429,"median":-107.874867,"eighty":-49.409876,"marketCap":21428268381},{"date":"2020-08-21","current":111.294641,"twenty":-146.720429,"median":-107.54787,"eighty":-49.282149,"marketCap":13606660262},{"date":"2020-08-28","current":113.297144,"twenty":-146.720429,"median":-107.159772,"eighty":-49.094704,"marketCap":13851482218},{"date":"2020-09-04","current":112.733477,"twenty":-146.720429,"median":-106.448863,"eighty":-48.818303,"marketCap":13782569372},{"date":"2020-09-11","current":106.874302,"twenty":-146.720429,"median":-105.912505,"eighty":-48.569168,"marketCap":13066238463},{"date":"2020-09-18","current":117.74715,"twenty":-146.720429,"median":-105.43525,"eighty":-48.312221,"marketCap":14395531009},{"date":"2020-09-25","current":114.795312,"twenty":-146.720429,"median":-104.968329,"eighty":-48.052471,"marketCap":14034645311},{"date":"2020-10-02","current":111.220475,"twenty":-146.720429,"median":-104.968329,"eighty":-47.767481,"marketCap":13597592783},{"date":"2020-10-09","current":116.960982,"twenty":-146.720429,"median":-104.968329,"eighty":-47.469759,"marketCap":14299415723},{"date":"2020-10-16","current":117.554316,"twenty":-146.720429,"median":-104.968329,"eighty":-47.31175,"marketCap":14371955562},{"date":"2020-10-23","current":115.002979,"twenty":-146.720429,"median":-104.968329,"eighty":-47.07446,"marketCap":14060034255},{"date":"2020-10-30","current":110.40464,"twenty":-146.720429,"median":-104.968329,"eighty":-46.453512,"marketCap":13497850504},{"date":"2020-11-06","current":16.333756,"twenty":-145.315182,"median":-104.024299,"eighty":-46.24616,"marketCap":13916768073},{"date":"2020-11-13","current":16.516158,"twenty":-144.868574,"median":-103.498065,"eighty":-45.910184,"marketCap":14072179785},{"date":"2020-11-20","current":16.181659,"twenty":-144.868574,"median":-102.889101,"eighty":-45.353548,"marketCap":13787178208},{"date":"2020-11-27","current":17.129762,"twenty":-144.868574,"median":-102.47937,"eighty":-34.458654,"marketCap":14594985226},{"date":"2020-12-04","current":16.961447,"twenty":-144.868574,"median":-101.666821,"eighty":-33.817892,"marketCap":14451576789},{"date":"2020-12-11","current":16.93588,"twenty":-144.868574,"median":-101.332926,"eighty":-32.987662,"marketCap":14429793229},{"date":"2020-12-18","current":18.930091,"twenty":-144.868574,"median":-100.855221,"eighty":-31.786506,"marketCap":16128910912},{"date":"2020-12-24","current":18.88961,"twenty":-144.868574,"median":-100.530187,"eighty":-31.699842,"marketCap":16094420276},{"date":"2020-12-31","current":18.682945,"twenty":-144.868574,"median":-100.130791,"eighty":-31.545183,"marketCap":15918336499},{"date":"2021-01-08","current":19.145278,"twenty":-144.868574,"median":-99.499409,"eighty":-31.239921,"marketCap":16312255876},{"date":"2021-01-15","current":17.677318,"twenty":-144.868574,"median":-99.011614,"eighty":-31.142754,"marketCap":15061516470},{"date":"2021-01-22","current":18.746862,"twenty":-144.868574,"median":-98.307572,"eighty":-30.998361,"marketCap":15972795399},{"date":"2021-01-29","current":17.636837,"twenty":-144.868574,"median":-97.576033,"eighty":-30.940261,"marketCap":15027025834},{"date":"2021-02-05","current":18.156695,"twenty":-144.868574,"median":-97.576033,"eighty":-30.85726,"marketCap":15469958221},{"date":"2021-02-12","current":18.544458,"twenty":-144.868574,"median":-97.576033,"eighty":-30.741472,"marketCap":15800342215},{"date":"2021-02-19","current":17.419519,"twenty":-144.868574,"median":-97.521381,"eighty":-30.612592,"marketCap":14841865573},{"date":"2021-02-26","current":16.477433,"twenty":-144.868574,"median":-95.195111,"eighty":-30.351921,"marketCap":14072205552},{"date":"2021-03-05","current":16.549346,"twenty":-144.931156,"median":-92.988484,"eighty":-30.193594,"marketCap":14133621026},{"date":"2021-03-12","current":16.344954,"twenty":-144.931156,"median":-92.037344,"eighty":-30.118727,"marketCap":13959064533},{"date":"2021-03-19","current":16.645154,"twenty":-144.931156,"median":-90.941505,"eighty":-29.706846,"marketCap":14215444382},{"date":"2021-03-26","current":16.070302,"twenty":-144.868574,"median":-89.639785,"eighty":-29.214173,"marketCap":13724504246},{"date":"2021-04-01","current":16.570636,"twenty":-144.868574,"median":-88.5032,"eighty":-28.439397,"marketCap":14151803994},{"date":"2021-04-09","current":16.408826,"twenty":-144.931156,"median":-87.602744,"eighty":-27.75353,"marketCap":14013613437},{"date":"2021-04-16","current":16.904902,"twenty":-144.931156,"median":-86.817737,"eighty":-27.498326,"marketCap":14437276592},{"date":"2021-04-23","current":16.838842,"twenty":-144.931156,"median":-86.272203,"eighty":-27.151224,"marketCap":14380859669},{"date":"2021-04-30","current":17.900998,"twenty":-144.931156,"median":-85.694758,"eighty":15.913176,"marketCap":14232904679},{"date":"2021-05-07","current":17.874568,"twenty":-144.931156,"median":-85.610935,"eighty":16.023777,"marketCap":14211889902},{"date":"2021-05-14","current":17.681503,"twenty":-144.931156,"median":-85.219763,"eighty":16.210666,"marketCap":14058386140},{"date":"2021-05-21","current":17.950414,"twenty":-144.931156,"median":-84.959558,"eighty":16.297129,"marketCap":14272194951},{"date":"2021-05-28","current":17.766543,"twenty":-144.931156,"median":-84.679572,"eighty":16.395247,"marketCap":14126000892},{"date":"2021-06-04","current":17.902148,"twenty":-144.931156,"median":-84.297713,"eighty":16.432736,"marketCap":14233819010},{"date":"2021-06-11","current":18.862875,"twenty":-144.931156,"median":-84.279085,"eighty":16.501579,"marketCap":14997682966},{"date":"2021-06-18","current":18.823802,"twenty":-144.931156,"median":-84.279085,"eighty":16.577449,"marketCap":14966616728},{"date":"2021-06-25","current":19.488036,"twenty":-144.931156,"median":-84.279085,"eighty":16.648523,"marketCap":15494742764},{"date":"2021-07-02","current":19.644327,"twenty":-144.931156,"median":-84.279085,"eighty":16.690717,"marketCap":15619007714},{"date":"2021-07-09","current":19.219125,"twenty":-144.931156,"median":-84.185949,"eighty":16.765656,"marketCap":15280933954},{"date":"2021-07-16","current":18.120495,"twenty":-144.931156,"median":-83.841344,"eighty":16.854046,"marketCap":14407424455},{"date":"2021-07-23","current":17.706785,"twenty":-144.931156,"median":-83.683013,"eighty":16.951792,"marketCap":14078487823},{"date":"2021-07-30","current":16.8013,"twenty":-144.931156,"median":-83.422231,"eighty":17.027349,"marketCap":14066283248},{"date":"2021-08-06","current":17.110693,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":14325311683},{"date":"2021-08-13","current":16.431784,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":13756919692},{"date":"2021-08-20","current":16.455874,"twenty":-144.931156,"median":-82.965863,"eighty":17.063524,"marketCap":13777088440},{"date":"2021-08-27","current":18.288928,"twenty":-144.931156,"median":-82.965863,"eighty":17.151762,"marketCap":15311746815},{"date":"2021-09-03","current":18.604292,"twenty":-144.931156,"median":-82.965863,"eighty":17.265235,"marketCap":15575774062},{"date":"2021-09-10","current":17.077843,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14297808844},{"date":"2021-09-17","current":17.029662,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14257471348},{"date":"2021-09-24","current":17.213624,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14411487243},{"date":"2021-10-01","current":16.89826,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14147459995},{"date":"2021-10-08","current":17.044992,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14270306006},{"date":"2021-10-15","current":16.620127,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13914602631},{"date":"2021-10-22","current":16.14927,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13520395283},{"date":"2021-10-29","current":913.742979,"twenty":-144.931156,"median":-82.965863,"eighty":17.356508,"marketCap":14544047003},{"date":"2021-11-05","current":967.9689,"twenty":-144.931156,"median":-82.965863,"eighty":17.405709,"marketCap":15407160981},{"date":"2021-11-12","current":942.70851,"twenty":-144.931156,"median":-82.965863,"eighty":17.560148,"marketCap":15005091360},{"date":"2021-11-19","current":1055.053805,"twenty":-144.931156,"median":-82.965863,"eighty":17.678992,"marketCap":16793291407},{"date":"2021-11-26","current":1010.184893,"twenty":-144.931156,"median":-82.965863,"eighty":17.719077,"marketCap":16079112949},{"date":"2021-12-03","current":956.780508,"twenty":-144.931156,"median":-82.965863,"eighty":17.763785,"marketCap":15229075350},{"date":"2021-12-10","current":979.157292,"twenty":-144.931156,"median":-82.965863,"eighty":17.780334,"marketCap":15585246612},{"date":"2021-12-17","current":997.497027,"twenty":-144.931156,"median":-82.965863,"eighty":17.854801,"marketCap":15877160172},{"date":"2021-12-23","current":1051.478133,"twenty":-144.931156,"median":-82.965863,"eighty":17.921454,"marketCap":16736377443},{"date":"2021-12-31","current":1019.0664,"twenty":-144.931156,"median":-82.965863,"eighty":18.068316,"marketCap":16220479893},{"date":"2022-01-07","current":971.77526,"twenty":-144.868574,"median":-82.756306,"eighty":18.102568,"marketCap":15467746814},{"date":"2022-01-14","current":1040.635774,"twenty":-144.868574,"median":-82.756306,"eighty":18.18902,"marketCap":16563799615},{"date":"2022-01-21","current":976.38903,"twenty":-144.868574,"median":-82.756306,"eighty":18.272526,"marketCap":15541184188},{"date":"2022-01-28","current":993.806011,"twenty":-144.868574,"median":-82.756306,"eighty":18.302,"marketCap":15818410273},{"date":"2022-02-04","current":1022.296039,"twenty":-144.868574,"median":-82.756306,"eighty":18.385092,"marketCap":16271886055},{"date":"2022-02-11","current":1048.594527,"twenty":-144.868574,"median":-82.756306,"eighty":18.50696,"marketCap":16690479084},{"date":"2022-02-18","current":978.811259,"twenty":-144.868574,"median":-82.756306,"eighty":18.612353,"marketCap":15579738809},{"date":"2022-02-25","current":-223.863547,"twenty":-146.720429,"median":-83.128851,"eighty":18.645295,"marketCap":14345176092},{"date":"2022-03-04","current":-219.184373,"twenty":-148.717362,"median":-83.543308,"eighty":18.645295,"marketCap":14045334603},{"date":"2022-03-11","current":-218.207922,"twenty":-159.853208,"median":-83.818061,"eighty":18.645295,"marketCap":13982763668},{"date":"2022-03-18","current":-234.549105,"twenty":-161.293219,"median":-83.967078,"eighty":18.645295,"marketCap":15029906670},{"date":"2022-03-25","current":-226.938537,"twenty":-162.185225,"median":-84.288399,"eighty":18.645295,"marketCap":14542221441},{"date":"2022-04-01","current":-227.656515,"twenty":-163.361234,"median":-84.633004,"eighty":18.645295,"marketCap":14588229481},{"date":"2022-04-08","current":-246.955768,"twenty":-164.641244,"median":-84.986921,"eighty":18.645295,"marketCap":15824925610},{"date":"2022-04-14","current":-238.225154,"twenty":-165.041247,"median":-85.857746,"eighty":18.645295,"marketCap":15265467837},{"date":"2022-04-22","current":-232.276832,"twenty":-165.973254,"median":-88.12096,"eighty":18.645295,"marketCap":14884299384},{"date":"2022-04-29","current":382.277246,"twenty":-166.445258,"median":-90.308931,"eighty":18.664196,"marketCap":15041462794},{"date":"2022-05-06","current":372.455987,"twenty":-166.445258,"median":-89.349626,"eighty":18.760072,"marketCap":14655025704},{"date":"2022-05-13","current":365.458317,"twenty":-166.445258,"median":-89.349626,"eighty":18.859197,"marketCap":14379688400},{"date":"2022-05-20","current":374.814577,"twenty":-166.445258,"median":-89.349626,"eighty":18.955948,"marketCap":14747829142},{"date":"2022-05-27","current":380.691624,"twenty":-166.445258,"median":-89.349626,"eighty":19.066512,"marketCap":14979073327},{"date":"2022-06-03","current":364.329924,"twenty":-166.445258,"median":-89.349626,"eighty":19.178673,"marketCap":14335289516},{"date":"2022-06-10","current":352.998976,"twenty":-166.445258,"median":-89.349626,"eighty":19.261875,"marketCap":13889450727},{"date":"2022-06-17","current":357.700614,"twenty":-166.445258,"median":-89.349626,"eighty":19.519294,"marketCap":14074446075},{"date":"2022-06-24","current":408.337255,"twenty":-166.509258,"median":-86.272203,"eighty":107.93637,"marketCap":16066845973},{"date":"2022-07-01","current":399.545192,"twenty":-166.509258,"median":-84.809963,"eighty":110.39574,"marketCap":15720904673},{"date":"2022-07-08","current":418.539809,"twenty":-166.509258,"median":-84.754081,"eighty":111.051374,"marketCap":16468285878},{"date":"2022-07-15","current":409.418632,"twenty":-166.509258,"median":-83.152135,"eighty":111.935442,"marketCap":16109394903},{"date":"2022-07-22","current":400.720602,"twenty":-166.509258,"median":-83.077626,"eighty":112.591077,"marketCap":15767153510},{"date":"2022-07-29","current":404.575945,"twenty":-166.509258,"median":-81.708522,"eighty":113.113211,"marketCap":15918849695},{"date":"2022-08-05","current":327.838991,"twenty":-166.509258,"median":-34.536978,"eighty":114.110012,"marketCap":17726254245},{"date":"2022-08-12","current":325.272938,"twenty":-166.509258,"median":-34.536978,"eighty":114.976279,"marketCap":17587507734},{"date":"2022-08-19","current":318.464838,"twenty":-166.509258,"median":-34.536978,"eighty":115.685314,"marketCap":17219393812},{"date":"2022-08-26","current":312.187472,"twenty":-166.509258,"median":-34.536978,"eighty":116.907582,"marketCap":16879976635},{"date":"2022-09-02","current":307.488024,"twenty":-166.509258,"median":-34.536978,"eighty":117.883617,"marketCap":16625877437},{"date":"2022-09-09","current":318.773561,"twenty":-166.509258,"median":-34.536978,"eighty":141.162306,"marketCap":17236086460},{"date":"2022-09-16","current":302.58276,"twenty":-166.509258,"median":-34.536978,"eighty":148.167383,"marketCap":16360649808},{"date":"2022-09-23","current":291.022801,"twenty":-166.509258,"median":-34.536978,"eighty":150.289725,"marketCap":15735602876},{"date":"2022-09-30","current":290.782684,"twenty":-166.509258,"median":-34.536978,"eighty":152.726136,"marketCap":15722619705},{"date":"2022-10-07","current":302.376944,"twenty":-166.509258,"median":-34.536978,"eighty":167.017841,"marketCap":16349521376},{"date":"2022-10-14","current":299.289715,"twenty":-166.509258,"median":-34.536978,"eighty":168.933976,"marketCap":16182594895},{"date":"2022-10-21","current":308.757218,"twenty":-166.509258,"median":-34.536978,"eighty":170.628042,"marketCap":16694502768},{"date":"2022-10-28","current":192.178834,"twenty":-166.509258,"median":-34.536978,"eighty":175.146289,"marketCap":16126110354},{"date":"2022-11-04","current":182.699459,"twenty":-166.509258,"median":-34.536978,"eighty":176.471621,"marketCap":15330676998},{"date":"2022-11-11","current":181.968573,"twenty":-166.509258,"median":-34.536978,"eighty":178.346579,"marketCap":15269346856},{"date":"2022-11-18","current":195.589638,"twenty":-166.509258,"median":-34.536978,"eighty":182.260927,"marketCap":16412317683},{"date":"2022-11-25","current":214.659129,"twenty":-166.509258,"median":-34.536978,"eighty":187.341695,"marketCap":18012476841},{"date":"2022-12-02","current":233.795065,"twenty":-166.509258,"median":-34.536978,"eighty":190.997361,"marketCap":19618211467},{"date":"2022-12-09","current":226.641237,"twenty":-166.509258,"median":-34.536978,"eighty":192.536436,"marketCap":19017919471},{"date":"2022-12-16","current":240.594523,"twenty":-166.509258,"median":-34.14536,"eighty":193.90401,"marketCap":20188767636},{"date":"2022-12-23","current":231.093,"twenty":-166.509258,"median":-33.835795,"eighty":195.798534,"marketCap":19391475791},{"date":"2022-12-30","current":229.210413,"twenty":-166.509258,"median":15.910621,"eighty":196.943179,"marketCap":19233504213},{"date":"2023-01-06","current":240.771708,"twenty":-166.509258,"median":15.99843,"eighty":199.747589,"marketCap":20203635549},{"date":"2023-01-13","current":249.653085,"twenty":-166.509258,"median":16.07919,"eighty":201.466427,"marketCap":20948889698},{"date":"2023-01-20","current":245.289915,"twenty":-166.509258,"median":16.188691,"eighty":202.812136,"marketCap":20582767336},{"date":"2023-01-27","current":259.730459,"twenty":-166.509258,"median":16.239185,"eighty":206.755441,"marketCap":21794502262},{"date":"2023-02-03","current":248.501386,"twenty":-166.509258,"median":16.333756,"eighty":220.240444,"marketCap":20852248263},{"date":"2023-02-10","current":242.432813,"twenty":-166.509258,"median":16.413891,"eighty":226.49506,"marketCap":20343022235},{"date":"2023-02-17","current":239.885785,"twenty":-166.509258,"median":16.442734,"eighty":229.440754,"marketCap":20129295983},{"date":"2023-02-24","current":226.065387,"twenty":-166.509258,"median":16.476957,"eighty":230.229225,"marketCap":18969598754},{"date":"2023-03-03","current":133.346847,"twenty":-166.509258,"median":16.516158,"eighty":230.229225,"marketCap":18876712940},{"date":"2023-03-10","current":119.234744,"twenty":-166.509258,"median":16.567292,"eighty":230.229225,"marketCap":16878989664},{"date":"2023-03-17","current":120.789579,"twenty":-166.509258,"median":16.617476,"eighty":230.229225,"marketCap":17099093629},{"date":"2023-03-24","current":119.564159,"twenty":-166.509258,"median":16.650384,"eighty":230.229225,"marketCap":16925621860},{"date":"2023-03-31","current":128.128926,"twenty":-166.445258,"median":16.685656,"eighty":229.9413,"marketCap":18138058956},{"date":"2023-04-06","current":127.246097,"twenty":-166.445258,"median":16.720301,"eighty":229.9413,"marketCap":18013084670},{"date":"2023-04-14","current":129.578349,"twenty":-166.509258,"median":16.77077,"eighty":230.229225,"marketCap":18343240618},{"date":"2023-04-21","current":127.575511,"twenty":-166.509258,"median":16.817229,"eighty":230.229225,"marketCap":18059716866},{"date":"2023-04-28","current":242.180022,"twenty":-166.509258,"median":16.855933,"eighty":231.407502,"marketCap":17343722249},{"date":"2023-05-05","current":250.17182,"twenty":-166.509258,"median":16.91578,"eighty":235.380867,"marketCap":17916054913},{"date":"2023-05-12","current":250.014562,"twenty":-166.573259,"median":16.941683,"eighty":237.019824,"marketCap":17904792857},{"date":"2023-05-19","current":241.732289,"twenty":-166.637259,"median":16.967171,"eighty":239.8282,"marketCap":17311657880},{"date":"2023-05-26","current":232.558885,"twenty":-166.637259,"median":17.014711,"eighty":240.585664,"marketCap":16654704583},{"date":"2023-05-30","current":231.916747,"twenty":-166.637259,"median":17.029662,"eighty":240.585664,"marketCap":16608717852},{"date":"2023-06-09","current":241.810918,"twenty":-166.73726,"median":17.061278,"eighty":241.008901,"marketCap":17317288908},{"date":"2023-06-16","current":251.194,"twenty":-166.74926,"median":17.112883,"eighty":241.385297,"marketCap":17989258281},{"date":"2023-06-23","current":250.591176,"twenty":-166.76126,"median":17.196104,"eighty":241.856963,"marketCap":17946087064},{"date":"2023-06-30","current":233.08308,"twenty":-166.76126,"median":17.241,"eighty":242.23058,"marketCap":16692244772},{"date":"2023-07-07","current":224.355242,"twenty":-166.76126,"median":17.308262,"eighty":242.23058,"marketCap":16067200635},{"date":"2023-07-14","current":224.643549,"twenty":-166.76126,"median":17.371372,"eighty":242.23058,"marketCap":16087847738},{"date":"2023-07-21","current":229.439928,"twenty":-166.76126,"median":17.48024,"eighty":242.23058,"marketCap":16431340462},{"date":"2023-07-28","current":226.871375,"twenty":-166.76126,"median":17.641098,"eighty":242.23058,"marketCap":16247393539},{"date":"2023-08-04","current":165.119407,"twenty":-166.76126,"median":17.695247,"eighty":242.23058,"marketCap":16510454583},{"date":"2023-08-11","current":171.085084,"twenty":-166.76126,"median":17.746561,"eighty":242.23058,"marketCap":17106968613},{"date":"2023-08-18","current":168.243389,"twenty":-166.76126,"median":17.778035,"eighty":242.23058,"marketCap":16822824706},{"date":"2023-08-25","current":175.281759,"twenty":-166.76126,"median":17.843539,"eighty":242.23058,"marketCap":17526598357},{"date":"2023-09-01","current":171.969585,"twenty":-166.76126,"median":17.901573,"eighty":242.23058,"marketCap":17195410756},{"date":"2023-09-08","current":170.162944,"twenty":-166.76126,"median":18.020515,"eighty":242.23058,"marketCap":17014762974},{"date":"2023-09-15","current":165.006492,"twenty":-166.76126,"median":18.09038,"eighty":242.23058,"marketCap":16499164096},{"date":"2023-09-22","current":162.352988,"twenty":-166.76126,"median":18.138595,"eighty":242.23058,"marketCap":16233837666},{"date":"2023-09-29","current":167.961101,"twenty":-166.76126,"median":18.255988,"eighty":242.23058,"marketCap":16794598490},{"date":"2023-10-06","current":164.272544,"twenty":-166.76126,"median":18.295251,"eighty":242.23058,"marketCap":16425775935},{"date":"2023-10-13","current":162.861106,"twenty":-166.76126,"median":18.372948,"eighty":242.23058,"marketCap":16284644855},{"date":"2023-10-20","current":155.427533,"twenty":-166.76126,"median":18.480739,"eighty":242.23058,"marketCap":15541354502},{"date":"2023-10-27","current":154.260745,"twenty":-166.76126,"median":18.544458,"eighty":242.382255,"marketCap":15424686142},{"date":"2023-11-03","current":102.060294,"twenty":-166.76126,"median":18.649124,"eighty":242.382255,"marketCap":15005006530},{"date":"2023-11-10","current":107.264835,"twenty":-166.76126,"median":18.746862,"eighty":242.382255,"marketCap":15770183276},{"date":"2023-11-17","current":111.736338,"twenty":-166.76126,"median":18.837592,"eighty":242.382255,"marketCap":16427588192},{"date":"2023-11-24","current":112.991947,"twenty":-166.76126,"median":18.922633,"eighty":242.382255,"marketCap":16612189000},{"date":"2023-12-01","current":116.69471,"twenty":-166.76126,"median":18.980092,"eighty":242.382255,"marketCap":17156573014},{"date":"2023-12-08","current":121.64027,"twenty":-166.76126,"median":19.115548,"eighty":242.331697,"marketCap":17883674154},{"date":"2023-12-15","current":125.073975,"twenty":-166.76126,"median":19.224871,"eighty":242.331697,"marketCap":18388500853},{"date":"2023-12-22","current":121.922141,"twenty":-166.76126,"median":19.421383,"eighty":242.331697,"marketCap":17925115152},{"date":"2023-12-29","current":124.446171,"twenty":-166.76126,"median":97.655587,"eighty":242.382255,"marketCap":18296200449},{"date":"2024-01-05","current":125.21491,"twenty":-166.76126,"median":106.724665,"eighty":242.432813,"marketCap":18409221351},{"date":"2024-01-12","current":122.998377,"twenty":-166.76126,"median":107.662485,"eighty":242.432813,"marketCap":18083344416},{"date":"2024-01-19","current":118.552498,"twenty":-166.79726,"median":109.532617,"eighty":242.575773,"marketCap":17429706862},{"date":"2024-01-26","current":116.91252,"twenty":-166.76126,"median":110.397223,"eighty":242.432813,"marketCap":17188595603},{"date":"2024-02-02","current":113.696625,"twenty":-166.76126,"median":111.153724,"eighty":242.432813,"marketCap":16715791494},{"date":"2024-02-09","current":112.940697,"twenty":-166.76126,"median":111.821225,"eighty":242.432813,"marketCap":16604654273},{"date":"2024-02-16","current":113.132882,"twenty":-166.76126,"median":112.099749,"eighty":242.432813,"marketCap":16632909499},{"date":"2024-02-23","current":101.214924,"twenty":-166.70126,"median":112.294622,"eighty":242.432813,"marketCap":16968175915},{"date":"2024-03-01","current":97.103598,"twenty":-165.901253,"median":112.199476,"eighty":242.382255,"marketCap":16278932666},{"date":"2024-03-08","current":96.664673,"twenty":-164.837246,"median":112.199476,"eighty":242.382255,"marketCap":16205349173},{"date":"2024-03-15","current":94.976502,"twenty":-164.11324,"median":112.199476,"eighty":242.382255,"marketCap":15922335740},{"date":"2024-03-22","current":94.661377,"twenty":-162.221226,"median":112.199476,"eighty":242.382255,"marketCap":15869506566},{"date":"2024-03-28","current":99.72589,"twenty":-162.081225,"median":112.199476,"eighty":242.382255,"marketCap":16718546865},{"date":"2024-04-05","current":97.790121,"twenty":-160.981216,"median":112.294622,"eighty":242.432813,"marketCap":16394024795},{"date":"2024-04-12","current":103.533211,"twenty":-131.648601,"median":112.294622,"eighty":242.432813,"marketCap":17356825158},{"date":"2024-04-19","current":101.959724,"twenty":-125.404689,"median":112.294622,"eighty":242.432813,"marketCap":17093037852},{"date":"2024-04-26","current":75.899547,"twenty":-124.450186,"median":112.199476,"eighty":242.382255,"marketCap":15593941332},{"date":"2024-05-03","current":77.447263,"twenty":-123.068927,"median":112.199476,"eighty":242.382255,"marketCap":15911927491},{"date":"2024-05-10","current":75.524945,"twenty":-121.619256,"median":112.199476,"eighty":242.382255,"marketCap":15516977501},{"date":"2024-05-17","current":71.135034,"twenty":-119.850332,"median":112.199476,"eighty":242.382255,"marketCap":14615048436},{"date":"2024-05-24","current":70.146149,"twenty":-118.560287,"median":112.199476,"eighty":242.382255,"marketCap":14411877047},{"date":"2024-05-31","current":68.833797,"twenty":-117.48525,"median":112.199476,"eighty":242.382255,"marketCap":14142247727},{"date":"2024-06-07","current":74.720898,"twenty":-116.644766,"median":112.199476,"eighty":242.382255,"marketCap":15351782072},{"date":"2024-06-14","current":77.853908,"twenty":-111.266324,"median":112.294622,"eighty":242.432813,"marketCap":15995474604},{"date":"2024-06-21","current":78.288278,"twenty":-109.731954,"median":112.389767,"eighty":242.575773,"marketCap":16084718112},{"date":"2024-06-28","current":77.170006,"twenty":-106.985723,"median":112.453746,"eighty":243.004654,"marketCap":15854963550},{"date":"2024-07-05","current":74.836422,"twenty":-105.324301,"median":112.453746,"eighty":243.004654,"marketCap":15375517047},{"date":"2024-07-12","current":77.548924,"twenty":15.962481,"median":112.453746,"eighty":243.004654,"marketCap":15932814269},{"date":"2024-07-15","current":78.574777,"twenty":15.978924,"median":112.453746,"eighty":243.004654,"marketCap":16143580851},{"date":"2024-08-02","current":78.205101,"twenty":16.215911,"median":112.851011,"eighty":244.594819,"marketCap":16067628929},{"date":"2024-08-09","current":65.219671,"twenty":16.277249,"median":112.851011,"eighty":244.594819,"marketCap":16734650053},{"date":"2024-08-16","current":66.1694,"twenty":16.362887,"median":112.851011,"eighty":244.594819,"marketCap":16978340065},{"date":"2024-08-23","current":66.792659,"twenty":16.42422,"median":112.851011,"eighty":244.594819,"marketCap":17138261636},{"date":"2024-08-30","current":67.794327,"twenty":16.45237,"median":112.851011,"eighty":244.594819,"marketCap":17395278446},{"date":"2024-09-06","current":63.156978,"twenty":16.479702,"median":112.851011,"eighty":244.594819,"marketCap":16205385808},{"date":"2024-09-13","current":62.607916,"twenty":16.537344,"median":112.851011,"eighty":244.594819,"marketCap":16064502520},{"date":"2024-09-20","current":52.98449,"twenty":16.577992,"median":112.851011,"eighty":244.594819,"marketCap":13595237319},{"date":"2024-09-27","current":52.116378,"twenty":16.619251,"median":112.851011,"eighty":244.594819,"marketCap":13372489417},{"date":"2024-10-04","current":50.573069,"twenty":16.6558,"median":112.851011,"eighty":244.594819,"marketCap":12976493147},{"date":"2024-10-11","current":51.827008,"twenty":16.697708,"median":112.851011,"eighty":244.594819,"marketCap":13298240116},{"date":"2024-10-18","current":51.545057,"twenty":16.760117,"median":112.851011,"eighty":244.594819,"marketCap":13225894644},{"date":"2024-10-25","current":52.227675,"twenty":16.799788,"median":112.851011,"eighty":244.594819,"marketCap":13401046840},{"date":"2024-10-31","current":39.424418,"twenty":16.832825,"median":112.851011,"eighty":244.594819,"marketCap":12706135252},{"date":"2024-11-08","current":39.584187,"twenty":16.900012,"median":112.851577,"eighty":244.597655,"marketCap":12757627091},{"date":"2024-11-15","current":38.791793,"twenty":16.930391,"median":112.851577,"eighty":244.597655,"marketCap":12502245849},{"date":"2024-11-22","current":37.520416,"twenty":16.956385,"median":112.851577,"eighty":244.597655,"marketCap":12092492365},{"date":"2024-11-29","current":39.046069,"twenty":16.983395,"median":112.851577,"eighty":244.597655,"marketCap":12584196546},{"date":"2024-12-06","current":39.122943,"twenty":17.042364,"median":112.851577,"eighty":244.597655,"marketCap":12608972338},{"date":"2024-12-13","current":39.182077,"twenty":17.063524,"median":112.851577,"eighty":244.597655,"marketCap":12628030640},{"date":"2024-12-20","current":38.43699,"twenty":17.120949,"median":112.851577,"eighty":244.597655,"marketCap":12387896040},{"date":"2024-12-27","current":39.631494,"twenty":17.201205,"median":112.851577,"eighty":244.597655,"marketCap":12772873732},{"date":"2025-01-03","current":39.318084,"twenty":17.236838,"median":112.851577,"eighty":244.597655,"marketCap":12671864733},{"date":"2025-01-10","current":40.435714,"twenty":17.313842,"median":112.852143,"eighty":244.60049,"marketCap":13032066634},{"date":"2025-01-17","current":36.219472,"twenty":17.376382,"median":112.852143,"eighty":244.60049,"marketCap":11673209730},{"date":"2025-01-24","current":36.77533,"twenty":17.466817,"median":112.852143,"eighty":244.60049,"marketCap":11852357765},{"date":"2025-01-31","current":37.774691,"twenty":17.638541,"median":112.852143,"eighty":244.60049,"marketCap":12174443062},{"date":"2025-02-07","current":38.046707,"twenty":17.688324,"median":112.852143,"eighty":244.60049,"marketCap":12262111249},{"date":"2025-02-14","current":38.094014,"twenty":17.743365,"median":112.852143,"eighty":244.60049,"marketCap":12277357890},{"date":"2025-02-21","current":30.715125,"twenty":17.776197,"median":112.852143,"eighty":244.60049,"marketCap":13111027516},{"date":"2025-02-28","current":30.891957,"twenty":17.826301,"median":112.852143,"eighty":244.60049,"marketCap":13186509834},{"date":"2025-03-07","current":31.826045,"twenty":17.900998,"median":112.870795,"eighty":244.603325,"marketCap":13585233872},{"date":"2025-03-14","current":31.553417,"twenty":18.033156,"median":112.870795,"eighty":244.603325,"marketCap":13468859871},{"date":"2025-03-21","current":32.000349,"twenty":18.097039,"median":112.870795,"eighty":244.603325,"marketCap":13659636923},{"date":"2025-03-28","current":32.550076,"twenty":18.156695,"median":112.870795,"eighty":244.603325,"marketCap":13894292697},{"date":"2025-04-04","current":30.158988,"twenty":18.272189,"median":112.870795,"eighty":244.603325,"marketCap":12873635468},{"date":"2025-04-11","current":25.171224,"twenty":18.291457,"median":112.852143,"eighty":244.60049,"marketCap":10744563568},{"date":"2025-04-17","current":26.423199,"twenty":18.323094,"median":112.852143,"eighty":244.60049,"marketCap":11278980279},{"date":"2025-04-25","current":28.184147,"twenty":18.45537,"median":112.870795,"eighty":244.603325,"marketCap":12030656625},{"date":"2025-05-01","current":28.610907,"twenty":18.510369,"median":112.838199,"eighty":244.603325,"marketCap":12212823087}],"updateTime":1746186369932}}}